YOLFTbeta
Guangdong Hybribio Biotech Co Ltd

Guangdong Hybribio Biotech Co Ltd

300639 · SHE · Healthcare / Diagnostics & Research

5.46CNY-0.20 (-3.53%)

Price History

Full chart

Market Stats

Previous Close5.66
Open5.69
Day Range5.42 – 5.69
52-Week Range4.75 – 10.07
Volume15.49M
Market Cap4.09B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.02
Dividend Yield0.00%
Beta0.43
50-Day Avg5.91
200-Day Avg6.09

About

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. The company offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. It operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. The company was founded in 2003 and is headquartered in Chaozhou, China.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMs. Jianyu Wang
  • Employees1.99K
  • HeadquartersD5-3-3-4, North High-tech Zone, Chaozhou, China, 521000, China
  • Websitehttps://www.hybribio.cn

Leadership

  • Ms. Jianyu WangGM & Director · b. 1961
  • Mr. Qinghui LiFinancial Director · b. 1965
  • Mr. Zhisheng GuanExecutive Deputy GM & Non Independent Director · b. 1984
  • Mr. Xiaochuan LiChief Medical Officer · b. 1964
  • Mr. Yi ChenDeputy GM & Board Secretary · b. 1979
  • Ms. Danrong WengDeputy General Manager · b. 1981
  • Cuihong LuoAccounting Supervisor

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue139.01M182.72M264.08M344.83M398.30M479.09M580.35M729.39M1.35B2.67B5.60B1.10B815.53M669.64M
Growth (%)-+31.44%+44.53%+30.58%+15.51%+20.28%+21.14%+25.68%+85.70%+97.34%+109.39%-80.27%-26.16%-17.89%
Cost of Revenue31.70M32.57M36.22M41.79M57.07M78.74M95.68M141.99M361.09M865.50M1.81B442.10M440.35M365.19M
Gross Profit107.32M150.15M227.87M303.04M341.23M400.34M484.68M587.40M993.40M1.81B3.79B662.35M375.18M304.45M
Gross Margin77.20%82.18%86.29%87.88%85.67%83.56%83.51%80.53%73.34%67.62%67.72%59.97%46.00%45.47%
Operating Expense86.18M114.18M155.76M231.08M260.82M290.25M358.66M431.15M524.56M733.75M1.60B619.75M1.20B440.84M
Operating Income21.14M35.97M72.11M71.96M80.41M110.09M126.01M156.25M468.84M1.07B2.19B42.60M-821.72M-136.39M
Operating Margin15.21%19.69%27.31%20.87%20.19%22.98%21.71%21.42%34.61%40.17%39.18%3.86%-100.76%-20.37%
EBITDA23.68M35.53M77.82M81.73M109.86M136.88M157.07M195.74M514.82M1.15B2.31B208.47M-673.15M-6.71M
EBITDA Margin17.03%19.45%29.47%23.70%27.58%28.57%27.06%26.84%38.01%42.87%41.18%18.88%-82.54%-1.00%
Net Income19.73M29.17M63.46M65.21M76.09M93.21M114.08M147.29M362.66M852.16M1.73B140.47M-654.88M-130.94M
Net Income Margin14.19%15.96%24.03%18.91%19.10%19.46%19.66%20.19%26.77%31.88%30.84%12.72%-80.30%-19.55%
R&D19.02M20.38M17.70M31.51M31.87M33.56M45.95M57.45M71.62M115.29M247.28M136.32M87.23M62.39M
R&D as % of Total Revenue13.68%11.15%6.70%9.14%8.00%7.00%7.92%7.88%5.29%4.31%4.42%12.34%10.70%9.32%
Interest Expense310.25K-1.20M225.60K671.30K269.37K367.88K322.82K1.42M8.63M9.92M6.10M2.28M3.18M
Interest Expense % of Total Revenue0.22%-0.45%0.07%0.17%0.06%0.06%0.04%0.11%0.32%0.18%0.55%0.28%0.48%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets169.25M271.02M385.66M493.83M579.15M1.07B1.19B1.30B2.86B4.23B6.73B5.73B4.62B4.15B
Total Liabilities38.96M79.64M41.06M80.11M77.49M98.74M108.17M112.33M322.69M756.37M1.50B627.05M576.44M485.86M
Total Equity130.29M191.38M344.60M412.01M489.49M960.60M967.45M1.08B2.39B3.19B4.91B4.86B4.11B3.75B
Cash23.61M102.16M107.65M47.25M51.41M185.76M62.80M257.33M390.96M521.97M1.02B764.93M712.36M798.56M
Total Debt321.49K39.71M491.94K353.70K10.00M23.45M140.09K231.93K75.27M185.15M139.49M47.79M79.61M-
Net Debt-23.29M-62.45M-107.16M-46.90M-41.41M-162.31M-62.66M-257.10M-315.69M-336.82M-885.28M-717.14M-632.75M-

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow16.08M22.89M34.65M48.47M63.63M79.17M80.39M112.83M311.30M631.34M1.31B319.60M78.78M341.61M
Investing Cash Flow-21.48M-14.57M-78.72M-129.82M-77.29M-333.83M-200.50M131.88M-1.19B-503.35M-604.75M-292.85M-110.35M-
Financing Cash Flow-4.69M68.05M52.15M18.32M20.00M388.16M-6.96M-43.72M1.02B8.50M-219.41M-294.40M-75.27M-
Capital Expenditure29.75M26.68M79.72M129.89M77.29M66.99M144.43M196.56M287.12M641.07M734.37M385.32M148.33M92.39M
Free Cash Flow-13.66M-3.79M-45.07M-81.42M-13.66M12.17M-64.04M-83.73M24.18M-9.73M574.85M-65.72M-69.55M249.21M
Dividends Paid136.88K1.33M1.03M-420.50K19.33K45.51M44.25M42.46M69.82M101.94M150.90M44.46M3.50M
FCF to OCF-84.95%-16.56%-130.06%-167.98%-21.47%15.38%-79.66%-74.21%7.77%-1.54%43.91%-20.56%-88.29%72.95%
Dividend Paid to FCF-1.00%-34.97%-2.28%--3.08%0.16%-71.06%-52.85%175.58%-717.60%17.73%-229.60%-63.92%1.40%

Earnings

Report DateJun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Apr 29, 2019Aug 24, 2019Oct 24, 2019Feb 19, 2020Apr 27, 2020Aug 7, 2020Oct 22, 2020Dec 31, 2020Apr 19, 2021Aug 10, 2021Oct 19, 2021Mar 25, 2022Apr 26, 2022Aug 15, 2022Oct 21, 2022Dec 31, 2022Apr 14, 2023Aug 30, 2023Oct 25, 2023Feb 23, 2024Apr 23, 2024Aug 28, 2024Sep 30, 2024Dec 31, 2024Apr 28, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------
EPS Actual0.050.040.050.020.060.050.060.040.110.110.160.070.270.360.180.730.500.590.471.151.091.170.360.530.090.08-0.05-0.02-0.10-0.29-0.61-0.04-0.10-0.06-0.01-0.000.05
Surprise-------------------------------------
Timing-------Pre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-market-Pre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-market-Pre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-market--Pre-market-----

Key Statistics & Ratios

Market Cap4.09B
Enterprise Value3.20B
Trailing P/E0.00
Forward P/E0.00
Price / Sales6.24
Price / Book1.05
EPS-0.02
Book Value6.07
Revenue (TTM)654.72M
Gross Profit (TTM)287.55M
EBITDA94.61M
Profit Margin-1.54%
Operating Margin11.08%
Return on Equity-0.53%
Return on Assets-0.83%
Shares Outstanding646.50M
Shares Float360.86M
Beta0.43
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
0.07May 23, 2024
20231×
0.23May 22, 2023
20221×
0.10Apr 29, 2022
20211×
0.04May 28, 2021
20201×
0.03May 21, 2020
20191×
0.03Apr 30, 2019
20181×
0.02May 9, 2018

Stock Splits

  • May 22, 20231.5:1
  • Apr 29, 20221.5:1
  • May 28, 20211.2514:1
  • Apr 30, 20191.2:1
  • May 9, 20182:1